927 related articles for article (PubMed ID: 15473954)
1. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
[TBL] [Abstract][Full Text] [Related]
3. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
[TBL] [Abstract][Full Text] [Related]
4. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
[TBL] [Abstract][Full Text] [Related]
5. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
7. STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.
Godshall CJ; Lentsch AB; Peyton JC; Scott MJ; Cheadle WG
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1044-8. PubMed ID: 11687437
[TBL] [Abstract][Full Text] [Related]
8. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
[TBL] [Abstract][Full Text] [Related]
9. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma.
Page KM; Chaudhary D; Goldman SJ; Kasaian MT
J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.
Matikainen S; Paananen A; Miettinen M; Kurimoto M; Timonen T; Julkunen I; Sareneva T
Eur J Immunol; 2001 Jul; 31(7):2236-45. PubMed ID: 11449378
[TBL] [Abstract][Full Text] [Related]
12. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.
Kaplan MH; Sun YL; Hoey T; Grusby MJ
Nature; 1996 Jul; 382(6587):174-7. PubMed ID: 8700209
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 regulates T helper 1 or 2 immune responses of human cord blood CD4+ V alpha 24+V beta 11+ natural killer T cells.
Fujibayashi Y; Fujimori Y; Kasumoto I; Kai S; Hara H; Okamura H; Tsutsui H; Ogawa H; Nakanishi K
Int J Mol Med; 2007 Aug; 20(2):241-5. PubMed ID: 17611643
[TBL] [Abstract][Full Text] [Related]
14. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
15. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
16. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
Stenström M; Sköld M; Andersson A; Cardell SL
Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
18. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.
Bessoles S; Fouret F; Dudal S; Besra GS; Sanchez F; Lafont V
J Leukoc Biol; 2008 Jul; 84(1):224-33. PubMed ID: 18456817
[TBL] [Abstract][Full Text] [Related]
19. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
20. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
